COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON PATIENTS WITH NSCLC WHO HAD DISEASE PROGRESSION FOLLOWING EGFR-TKI TREATMENT

Wulandari Laksmi; Wiriansya Edward Pandu

首页> 外文期刊>Respirology : >COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON PATIENTS WITH NSCLC WHO HAD DISEASE PROGRESSION FOLLOWING EGFR-TKI TREATMENT

【24h】

COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON PATIENTS WITH NSCLC WHO HAD DISEASE PROGRESSION FOLLOWING EGFR-TKI TREATMENT

机译：双铂加上EGFR-TKI与双铂的化疗响应和不良反应对患有疾病进展的患者进行化疗反应和双铂的不良反应比较

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Respirology :》 |2017年第3期|共2页
作者
Wulandari Laksmi; Wiriansya Edward Pandu;
展开▼
作者单位

Airlangga Univ Dr Soetomo Hosp Fac Med Dept Pulmonol &

Resp Med Sby Surabaya Indonesia;

Airlangga Univ Dr Soetomo Hosp Fac Med Dept Pulmonol &

Resp Med Sby Surabaya Indonesia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词
NSCLC; EGFR-TKI; disease progression; double-platinum;

机译：nsclc;egfr-tki;疾病进展;双铂;

相似文献

外文文献
中文文献
专利

1. COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON PATIENTS WITH NSCLC WHO HAD DISEASE PROGRESSION FOLLOWING EGFR-TKI TREATMENT [J] . Wulandari Laksmi, Wiriansya Edward Pandu Respirology : . 2017,第Suppla3期

机译：双铂加上EGFR-TKI与双铂的化疗响应和不良反应对患有疾病进展的患者进行化疗反应和双铂的不良反应比较
2. Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer [J] . Qi Huiwei, Jiang Sen, Yu Dong, Medical oncology . 2015,第12期

机译：晚期EGFR突变非小细胞肺癌患者继续进行EGFR-TKI治疗与超选择性动脉灌注化疗相结合，超越疾病进展
3. Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations. [J] . Eva Regina Haspinger, Francesco Agustoni, Valter Torri, Critical reviews in oncology/hematology . 2015,第2期

机译：是否有证据表明EGFR-TKI之间有不同的作用？ EGFR酪氨酸激酶抑制剂（TKIs）与化学疗法的系统评价和荟萃分析是携带EGFR突变患者的一线治疗方法。
4. Design of optimal disease and patient-specific chemotherapy protocols for the treatment of Acute Myeloid Leukaemia (AML) [C] . E. Pefani, N. Panoskaltsis, A. Mantalaris International Symposium on Process Systems Engineering . 2012

机译：用于治疗急性髓性白血病（AML）的最佳疾病和患者特异性化疗方案的设计
5. The Comparison of Prescriptions Dispensed For Methadone Maintenance Patients to Non-Methadone Maintenance Patients for the Treatment of Chronic Diseases using PharmaNet Data [D] . Maruyama, Anna. 2012

机译：使用PharmaNet数据比较美沙酮维持治疗患者和非美沙酮维持治疗患者治疗慢性疾病的处方比较
6. Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation [O] . Miaomiao Wen, Jinghua Xia, Ying Sun, 2018

机译：EGFR-TKIs联合化疗与单纯EGFR-TKIs或EGFR突变的晚期NSCLC患者联合使用
7. COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON NSLCLC PATIENTS WITH DISEASE PROGRESSION AND EGFR-TKI TREATMENT [O] . Laksmi Wulandari, Edward Pandu Wiriansya 2017

机译：双铂加上紫杉醇与双铂患者对疾病进展和EGFR-TKI治疗的NSLCLC患者进行化疗反应和双铂的不良反应的比较
8. Psychological Stress, Neutropenia and Infectious Disease in Patients Receiving Chemotherapy Treatment for Breast Cancer [R] . Bovbjerg, D. 1999

机译：乳腺癌化疗治疗患者的心理应激，中性粒细胞减少和传染病

COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON PATIENTS WITH NSCLC WHO HAD DISEASE PROGRESSION FOLLOWING EGFR-TKI TREATMENT

著录项

相似文献

相关主题

期刊订阅